Quarterly report · Q2
2112.TEDINET S100S41D
Period2023-04-01 → 2023-09-30
Filed2023-11-02
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥15.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net sales |
| Revenue | ¥27.9bn | 2022-04-01 → 2023-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥13.4bn | 2022-04-01 → 2022-09-30 | Cons. | Net sales |
| Operating income | ¥546m | 2023-04-01 → 2023-09-30 | Cons. | Operating income |
| Operating income | ¥274m | 2022-04-01 → 2022-09-30 | Cons. | Operating income |
| Ordinary income | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥731m | 2022-04-01 → 2023-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥244m | 2022-04-01 → 2022-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥498m | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥901m | 2023-04-01 → 2023-09-30 | Cons. | Profit loss |
| Net income | ¥138m | 2022-04-01 → 2022-09-30 | Cons. | Profit loss |
| Total assets | ¥26.2bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥25.9bn | at 2023-03-31 | Cons. | Assets |
| Total assets | ¥25.2bn | at 2022-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥13.7bn | at 2023-09-30 | Cons. | Liabilities |
| Total liabilities | ¥14.8bn | at 2023-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥12.5bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥11.0bn | at 2023-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.2bn | at 2023-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.3bn | at 2022-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥3.5bn | at 2022-03-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥434m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥447m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥104m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥76m | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥374m | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥172m | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.2bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥1.4bn | 2022-04-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥33.01 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.48 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥18.28 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥5.1 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-3.14 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 47.7% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.6% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 41.2% | at 2022-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2023-04-01 → 2023-09-30 | ¥67m |
| Otherother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥8m |
| Otherother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥37m |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥59m |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥621m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥964m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥927m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥37m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥211m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥14.6bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥919m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-04-01 → 2023-09-30 | ¥15.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥59m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-04-01 → 2023-09-30 | ¥1.2bn |
| Otherother segments | revenue | 2022-04-01 → 2022-09-30 | ¥67m |
| Otherother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥59m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥8m |
| Otherother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥30m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥55m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥577m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥925m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥891m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥34m |
| jpcrp040300-q2r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥238m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥12.4bn |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥13m |
| jpcrp040300-q2r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥582m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-09-30 | ¥13.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥55m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-09-30 | ¥851m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 498
| Item | Context | Value | Unit |
|---|---|---|---|
| Deferred gains or losses on hedges net of tax oci | CurrentYTDDuration | 8000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | Prior1YTDDuration | -1000000 | JPY |
| Remeasurements of defined benefit plans net of tax oci | CurrentYTDDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | Prior1YTDDuration | -0 | JPY |
| Share of other comprehensive income of associates accounted for using equity method oci | CurrentYTDDuration | 0 | JPY |
| Other comprehensive income | Prior1YTDDuration | -16000000 | JPY |
| Other comprehensive income | CurrentYTDDuration | 705000000 | JPY |
| Comprehensive income | Prior1YTDDuration | 122000000 | JPY |
| Comprehensive income | CurrentYTDDuration | 1607000000 | JPY |
| Comprehensive income attributable to owners of the parent | Prior1YTDDuration | 122000000 | JPY |
| Comprehensive income attributable to owners of the parent | CurrentYTDDuration | 1607000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 244000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 1188000000 | JPY |
| Depreciation and amortization ope cf | Prior1YTDDuration | 320000000 | JPY |
| Depreciation and amortization ope cf | CurrentYTDDuration | 292000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | Prior1YTDDuration | -62000000 | JPY |
| Increase decrease in net defined benefit liability ope cf | CurrentYTDDuration | -7000000 | JPY |
| Increase decrease in provision for bonuses ope cf | Prior1YTDDuration | -2000000 | JPY |
| Increase decrease in provision for bonuses ope cf | CurrentYTDDuration | -4000000 | JPY |
| Interest and dividends income ope cf | Prior1YTDDuration | -81000000 | JPY |
| Interest and dividends income ope cf | CurrentYTDDuration | -735000000 | JPY |
| Interest expenses ope cf | Prior1YTDDuration | 45000000 | JPY |
| Interest expenses ope cf | CurrentYTDDuration | 49000000 | JPY |
| Foreign exchange losses gains ope cf | Prior1YTDDuration | -11000000 | JPY |
| Foreign exchange losses gains ope cf | CurrentYTDDuration | -5000000 | JPY |
| Equity in earnings losses of affiliates ope cf | Prior1YTDDuration | 85000000 | JPY |
| Equity in earnings losses of affiliates ope cf | CurrentYTDDuration | 57000000 | JPY |
| Loss gain on sales of investment securities ope cf | Prior1YTDDuration | － | JPY |
| Loss gain on sales of investment securities ope cf | CurrentYTDDuration | -1000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | Prior1YTDDuration | -10000000 | JPY |
| Decrease increase in notes and accounts receivable trade ope cf | CurrentYTDDuration | -242000000 | JPY |
| Decrease increase in inventories ope cf | Prior1YTDDuration | -504000000 | JPY |
| Decrease increase in inventories ope cf | CurrentYTDDuration | -473000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | Prior1YTDDuration | -186000000 | JPY |
| Increase decrease in notes and accounts payable trade ope cf | CurrentYTDDuration | -144000000 | JPY |
| Other net ope cf | Prior1YTDDuration | 352000000 | JPY |
| Other net ope cf | CurrentYTDDuration | 10000000 | JPY |
| Subtotal ope cf | Prior1YTDDuration | 189000000 | JPY |
| Subtotal ope cf | CurrentYTDDuration | -17000000 | JPY |
| Interest and dividends income received ope cf inv cf | Prior1YTDDuration | 81000000 | JPY |
| Interest and dividends income received ope cf inv cf | CurrentYTDDuration | 736000000 | JPY |
| Interest expenses paid ope cf fin cf | Prior1YTDDuration | -46000000 | JPY |
| Interest expenses paid ope cf fin cf | CurrentYTDDuration | -49000000 | JPY |
| Income taxes paid ope cf | Prior1YTDDuration | -120000000 | JPY |
| Income taxes paid ope cf | CurrentYTDDuration | -234000000 | JPY |
| Net cash provided by used in operating activities | Prior1YTDDuration | 104000000 | JPY |
| Net cash provided by used in operating activities | CurrentYTDDuration | 434000000 | JPY |
| Purchase of property plant and equipment inv cf | Prior1YTDDuration | -131000000 | JPY |
| Purchase of property plant and equipment inv cf | CurrentYTDDuration | -135000000 | JPY |
| Purchase of intangible assets inv cf | Prior1YTDDuration | -4000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |